semaglutide cardiovascular news New Science Suggests Improves CV Outcomes Beyond Weight Loss International Clinical Trial Finds that

doi: 10.1146/annurev.pathmechdis.2.010506.091842 61 BryantKLStalneckerCAZeitouniDKlompJEPengSTikunovAPet al

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society

When administered in therapeutic doses, semaglutide helps reduce appetite, increase satiety after meals, and slow gastric emptying-mechanisms that collectively support consistent caloric control without extreme dietary restriction

Wegovy can be injected in the abdomen, thigh or upper arm at any time during the day, with or without food

However, oral absorption is less efficient and more variable, so the buildup to therapeutic levels may take longer

doi: 10.1161/CIRCULATIONAHA.117.028136 22 ChangWZhuFZhengHZhouZMiaoPZhaoLet al